DPP4 and chronic myelogenous leukemia, BCR-ABL1 positive: To our knowledge, this is the first report that prospectively monitored the behavior of circulating CML-specific CD26+LSCs in CML patients during TFR, exploring their possible active role in inducing molecular relapse.